Free Trial
NASDAQ:HRTS

Tema Cardiovascular and Metabolics ETF (HRTS) Price, Holdings, & News

$33.94
-0.23 (-0.67%)
(As of 09/6/2024 ET)
Today's Range
$33.58
$34.43
50-Day Range
$32.05
$35.90
52-Week Range
$26.26
$36.03
Volume
35,128 shs
Average Volume
26,269 shs
Market Capitalization
$86.21 million
Assets Under Management
$85.13 million
Dividend Yield
N/A
Net Expense Ratio
0.75%
HRTS stock logo

About Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

HRTS Stock Price History

HRTS ETF News Headlines

Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
NVO Mar 2024 131.000 put
XLV Apr 2024 144.500 put
Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
See More Headlines
Receive HRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Tema Global
Fund Name
Tema Cardiovascular and Metabolics ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:HRTS
Inception Date
11/20/2023
Fund Manager
David Song, Yuri Khodjamirian
Previous Symbol
NASDAQ:HRTS
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
45

Fund Statistics

Assets Under Management
$85.13 million
Average Daily Volume
$0.00
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
11,800 shs

Miscellaneous

Beta
0.93
Creation Unit
10,000
Creation Fee
$500.00
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Tema Cardiovascular and Metabolics ETF Expenses

TypeHRTSTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.55%0.49%0.52%
Other Expenses0.00%0.57%0.49%0.41%0.54%
Total Expense0.99%0.73%0.71%0.63%0.71%
Fee Waiver-0.24%-0.74%-0.53%-0.33%-0.58%
Net Expense0.75%0.59%0.61%0.56%0.59%

Tema Cardiovascular and Metabolics ETF (HRTS) Holdings & Exposure

HRTS Sector Exposure

HRTS Industry Exposure


HRTS ETF - Frequently Asked Questions

How have HRTS shares performed this year?

Tema Cardiovascular and Metabolics ETF's stock was trading at $30.61 at the start of the year. Since then, HRTS stock has increased by 10.9% and is now trading at $33.94.
View the best growth stocks for 2024 here
.

Who are Tema Cardiovascular and Metabolics ETF's major shareholders?

Top institutional investors of Tema Cardiovascular and Metabolics ETF include Sterling Investment Advisors Ltd. (6.03%).

How do I buy shares of Tema Cardiovascular and Metabolics ETF?

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HRTS) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners